Дуо-Септол

Quick links

Choose a section

Quick links to important sections

Advertisements

Дуо-Септол

Advertisements
Advertisements

Treatment option: Brucellosis

Advertisements

Overview of Дуо-Септол

What is Дуо-Септол? Overview

Property Description
Active ingredients Sulfamethoxazole, Trimethoprim
Form Tablets, Oral Suspension, Solution for Intravenous Infusion
Pharmacological class Antimicrobial Agent / Combination Antibacterial
Common purpose Combating bacterial infections
Origin Synthetic

What Type of Medicine is Дуо-Септол? (Defining the Entity)

Дуо-Септол is a synthetic, fixed-dose combination antimicrobial agent that is globally recognized by its International Nonproprietary Name (INN), Co-trimoxazole. This medication is classified as a broad-spectrum antibiotic belonging to the group of sulfonamides combined with a dihydrofolate reductase inhibitor. This classification confirms the drug's fundamental function is based on interrupting bacterial metabolism, a principle that allows it to act against a wide range of susceptible microorganisms. The drug is exclusively dispensed as a prescription-only medication.


Composition: The Synergy of Sulfamethoxazole and Trimethoprim

The efficacy of the drug relies on the two active ingredients: Sulfamethoxazole and Trimethoprim, which are deliberately paired to achieve a potent combined action known as synergism. This pairing ensures a dual-step interference with the bacterial life cycle, specifically by blocking the sequential synthesis of essential folic acid within the bacterial cell. Co-trimoxazole is considered an important component in many health systems. Дуо-Септол is prepared for administration in several forms, including oral tablets, an accessible oral suspension (liquid), and a specialized solution for intravenous infusion, allowing for both oral and intravenous use.


What is the General Purpose of This Combination Drug?

The general purpose of this combination is to achieve a powerful bactericidal effect against susceptible bacteria, meaning the drug actively kills the infectious microorganisms rather than merely stopping their growth. By employing the sequential blockade mechanism across two distinct metabolic steps, the drug efficiently eliminates a broad range of bacterial pathogens. This coordinated action provides a therapeutic advantage for addressing the underlying bacterial infection, such as those that might affect the urinary tract or respiratory system.

Advertisements

What side effects are possible with Дуо-Септол?

The drug name Дуо-Септол (Duo-Septol) is typically associated with pharmaceutical products containing a combination of Sulfamethoxazole and Trimethoprim (co-trimoxazole), an established antibiotic therapy. The safety information below is based on the known, officially documented risk profiles for this active ingredient combination, as defined by major health authorities.

Serious and Clinically Significant Adverse Reactions

The most serious safety concerns associated with the Sulfamethoxazole/Trimethoprim combination are hypersensitivity reactions. These include life-threatening dermatologic events such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), which can occur rapidly and require immediate medical attention. Other serious reactions involve the blood system, including: agranulocytosis, aplastic anemia, and drug-induced thrombocytopenia, necessitating regular hematologic monitoring during prolonged therapy.

Clostridium difficile-associated diarrhea (CDAD) has been reported, sometimes months after treatment completion, and requires prompt evaluation.

Common Adverse Reactions and Systemic Effects

Adverse reactions that are frequently reported, typically occurring in the Common frequency band, include gastrointestinal disturbances (nausea, vomiting, loss of appetite) and dermatological effects such as rash or urticaria.

Other systemic effects and safety considerations include:

  • Dose-related toxicity: The drug can interfere with folate metabolism, which may necessitate caution in patients with existing folate deficiency. The risk of hyperkalemia (high potassium) and hyponatremia (low sodium) is present, particularly in older adult populations and in those with pre-existing conditions like renal impairment or diabetes.
  • Photosensitivity: The medication can increase skin sensitivity to UV exposure, requiring protective measures against sunlight and tanning beds.
  • Population-Specific Warnings: The combination is generally contraindicated in infants under two months old due to the risk of kernicterus. Caution is required in patients with pre-existing hepatic or severe renal impairment, as well as those with severe allergies, asthma, or certain enzyme deficiencies like G6PD deficiency.
Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The information below describes the potential consequences and required actions in case of an overdose with Дуо-Септол (Co-trimoxazole), as documented in official regulatory sources.

Documented Overdose Presentations

Symptoms of an acute overdose may include feeling sick (nausea), being sick (vomiting), dizziness, and confusion. An overdose may also result in mental depression, drowsiness, headache, and potential signs of jaundice (yellowing of the skin or eyes) or facial swelling.

A particular risk noted for chronic overdose (long-term exposure to high doses) is the development of bone marrow depression, which can lead to severe blood disorders such as anemia or problems with blood clotting.

Emergency Response

Immediate medical help is required upon any suspicion of an overdose. The core regulatory instruction is to contact a doctor or the nearest hospital emergency department immediately for advice if you accidentally take too many tablets.

Call emergency services immediately if the person who has overdosed has severe symptoms, such as collapsing, experiencing a seizure, having trouble breathing, or cannot be awakened. These represent life-threatening emergencies requiring the fastest possible professional intervention.

Advertisements

Therapeutic Uses of Дуо-Септол

This therapeutic category involves products commonly used when short-term symptomatic assistance is needed for acute discomfort in the mouth and throat. This class of product is relevant when supportive symptom management is appropriate.

Дуо-Септол is applied across therapeutic domains where additional symptomatic support is needed, helping patients cope more steadily with difficult symptomatic episodes. It is generally used across conditions presenting with acute episodes, such as those involving minor soreness, localized irritation, and pain associated with heightened physiological activity.

The medication helps address symptom clusters that may appear suddenly, focusing on the symptoms related to physical discomfort and inflammatory or irritative states. It may assist with maintaining functional stability and supports general well-being during symptomatic phases, particularly when symptoms interfere with routine activities like swallowing and speaking. This action supports day-to-day comfort during periods of heightened symptoms.


Quick Fact: Relief for Soreness and Local Irritation


Regulatory References

  1. Health Canada Category IV Monograph on Throat Lozenges
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Дуо-Септол (Co-trimoxazole) — Official Regulatory Information

Дуо-Септол (Sulfamethoxazole/Trimethoprim) is officially permitted for use in adults and children typically mathbfge 2 months of age [1.4, 2.2]. Eligibility is strictly defined by regulatory guidelines, focusing on pre-existing health status and age [2.3].

The medicine is strictly contraindicated (must not be used) in patients with:

  • Hypersensitivity: Known allergy to sulfonamides, trimethoprim, or any component of the formulation [1.6, 2.3].
  • Severe Organ Dysfunction: Severe impairment of hepatic or renal function [1.6, 4.2].
  • Blood Disorders: Documented megaloblastic anemia due to folate deficiency, acute porphyria, or a history of drug-induced immune thrombocytopenia [1.6, 1.7, 1.2].
  • Infants: Those under 2 months of age [1.4, 2.3].

Conditional Use and Restrictions:

Population/Condition Eligibility Status Key Restriction (Regulatory Basis)
Renal Impairment Conditional Use is not recommended if creatinine clearance is mathbf< 15 mL/min [4.3]. Moderate impairment requires a mandated dose reduction [2.1].
Pregnancy/Lactation Prohibited/Restricted Contraindicated at term and generally in the first trimester. Not recommended for nursing mothers, especially if the infant is premature, jaundiced, or G6PD-deficient [1.5, 3.1].
Elderly Permitted with Caution Use requires close monitoring due to increased susceptibility to severe adverse reactions [2.1, 4.2].

Eligibility is also restricted in patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency due to the risk of hemolytic anemia [1.2]. Official eligibility is determined solely by these exclusion criteria and mandatory cautious use conditions [2.2].

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information classifies several drug combinations with Дуо-Септол (Co-trimoxazole) based on the risk of clinically significant outcomes, primarily involving pharmacokinetic and pharmacodynamic interactions.

Strictly Contraindicated Combinations

Certain combinations are strictly contraindicated due to the documented risk of severe or fatal adverse events. Co-administration with Dofetilide is prohibited because it significantly increases Dofetilide plasma concentrations, posing a risk of Torsades de pointes. Similarly, the combination with Clozapine is contraindicated due to an increased risk of fatal agranulocytosis.


Pharmacokinetic and Pharmacodynamic Interactions

The co-administration of Дуо-Септол with other medicines may alter their metabolism or clearance, resulting in modified drug exposure. Co-use with Phenytoin and Warfarin is documented to increase their respective plasma levels and effects, with Warfarin co-use leading to an enhanced risk of bleeding. The combination with Methotrexate is restricted as it increases free plasma levels of the antifolate agent, substantially increasing the risk of haematological toxicity.

Pharmacodynamic interactions pose a risk of additive effects, notably the combination with ACE Inhibitors or ARBs, which is associated with a risk of severe hyperkalaemia (high potassium levels). Additionally, the interaction with Thiazide diuretics specifically in elderly patients is noted to increase the risk of thrombocytopenia (low platelet count).

Advertisements

Mechanism of Action

How Дуо-Септол Works: The Mechanism of Action

The mechanism of action for Дуо-Септол is centered on the sequential blockade of the bacterial folic acid synthesis pathway.

Sequential Blockade of Bacterial Folate Synthesis

The two active ingredients interfere with distinct, consecutive steps. Sulfamethoxazole acts as a competitive inhibitor of the enzyme dihydropteroate synthase, thereby preventing the initial formation of dihydrofolic acid. Subsequently, Trimethoprim inhibits the enzyme dihydrofolate reductase, blocking the conversion to the essential cofactor, tetrahydrofolic acid (THF). This dual inhibition is highly selective, exploiting the bacterial necessity for de novo folate synthesis, a process not required by human cells.

Cessation of DNA and RNA Production

The physiological consequence of the induced folate deficiency is the immediate and complete halt of the bacterial cell's ability to produce purines and other necessary building blocks for DNA and RNA. This targeted shutdown of the genetic machinery prevents replication and survival, leading directly to the killing (bactericidal elimination) of the susceptible microorganisms.

Synergy and Conversion to Bactericidal Action

The combined action of the two agents achieves synergism, resulting in the conversion from a primarily growth-inhibiting (bacteriostatic) mechanism to an actively killing (bactericidal) mechanism. This robust action facilitates the reduction of the bacterial population, which is the resulting physiological effect of eliminating the bacterial population.

Advertisements

Dosage and Administration Information

How to Use Дуо-Септол: Administration Guidelines

Дуо-Септол (Co-trimoxazole) is administered through two primary routes: the oral route (tablets and suspension) and intravenous (IV) infusion (solution for infusion). Administration is based on specific dosage, frequency, and conditions for use.

Standard Dosage and Frequency

The standard adult dose for acute infections is one Double Strength (DS) tablet, containing 800 mg Sulfamethoxazole (SMX) and 160 mg Trimethoprim (TMP), taken every 12 hours. Treatment typically continues until the patient has been symptom-free for two days, with most courses requiring a minimum of five days.

For severe infections, such as the treatment of Pneumocystis jirovecii Pneumonia (PJP), a higher, weight-based dose is administered, divided into doses given every 6 hours.

Administration Requirements

Administration Type Key Procedural Instructions
Oral This form is taken with a full glass of water or plenty of fluids to minimize crystalluria. It may be taken with food to reduce gastrointestinal upset.
IV Infusion The concentrate is diluted in compatible infusion fluid before use. It is delivered via slow IV infusion over 60 to 90 minutes, not as a rapid injection.

Population-Specific Use Rules

  • Pediatric Dosing: Dosing for children over 2 months of age is calculated based on body weight and administered in two divided doses daily. Use is not recommended in infants less than two months old.
  • Renal Impairment: For adults with a creatinine clearance (CrCl) between 15 and 30 mL/min, the dose is reduced by half the standard regimen. For CrCl < 15 mL/min, use is generally not recommended.

If a dose is missed, the general practice is not to take a double dose. For doses taken once or twice daily, the missed dose is taken if it is less than six hours from when it was due; otherwise, the missed dose is omitted.

Advertisements

Recent Clinical Evidence

Recent Clinical Evidence for Trimethoprim-Sulfamethoxazole (TMP-SMX)

Trimethoprim-sulfamethoxazole (TMP-SMX) is a long-established combination antibiotic whose clinical utility continues to be evaluated in contemporary research settings, particularly against drug-resistant bacteria and in prophylactic care.


Efficacy Against Specific Infections

Recent studies have focused on the role of TMP-SMX in treating infections where antimicrobial resistance is a concern. The combination's ability to create a synergistic anti-folate effect is utilized across several indications.

  • Skin and Soft Tissue Infections (SSTIs): Research has examined the effectiveness of TMP-SMX for SSTIs caused by methicillin-resistant Staphylococcus aureus (MRSA). A comparison between standard and higher doses for these infections found similar rates of clinical resolution.
  • Pneumocystis Pneumonia (PCP): Clinical evidence consistently supports the use of TMP-SMX as the standard first-line therapy for treating PCP, an opportunistic fungal infection, in both HIV-positive and HIV-negative immunocompromised patients. Trials have explored combination regimens, such as TMP-SMX plus an echinocandin, which in some systematic reviews resulted in significantly lower mortality compared to monotherapy for PCP patients.

Prophylactic and Safety Profile Review

Studies also investigate the compound's use in preventing infection and detailing its adverse event profile in specific populations.

Area of Research Key Research Focus Observed Outcome (Summary)
Prophylaxis (Prevention) Preventing PCP in HIV-negative immunocompromised patients. Analysis indicated a lower incidence of PCP in the TMP-SMX group compared to controls. However, the rate of drug discontinuation was higher in the TMP-SMX group due to adverse events.
Dosing/Toxicity Safety of lower versus standard doses for PCP treatment. Meta-analyses suggested that reduced treatment doses (e.g., le 10 mg/kg/day of the TMP component) may reduce adverse drug events without a statistically significant difference in mortality compared to standard doses.

Ongoing clinical trials continue to evaluate the potential of TMP-SMX prophylaxis following acute kidney injury (AKI) to prevent post-discharge infections, demonstrating continued research interest in expanding its preventative role.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Дуо-Септол (FAQ)


Q: Can Дуо-Септол be used for children?

Official prescribing information states that the drug is not recommended for use in infants less than two months of age. For children aged two months and older, eligibility is based on a healthcare professional's assessment, and official documents describe that dosing for eligible children is based on body weight.


Q: Are there specific food or drinks that should be avoided while taking Дуо-Септол?

Official guidance on Дуо-Септол does not typically list specific foods that must be avoided entirely. However, patients may need to monitor or limit foods high in potassium, particularly if instructed due to existing conditions or co-medication that may affect potassium levels.


Q: Is the medication intended for short-term or long-term use?

Дуо-Септол is indicated for both short-term treatment of acute bacterial infections and long-term prophylaxis (prevention) in specific populations. For acute infections, a short duration of use is generally described, while preventative use may extend over longer periods as directed by a specialist.


Q: Has Дуо-Септол been studied in older adults?

Official regulatory documents note that use in older adults requires close clinical monitoring. Official warnings note that this population may have an increased susceptibility to certain severe adverse reactions, such as the risk of low platelet count (thrombocytopenia), especially when the drug is used alongside specific diuretics.


Q: What official documents describe who is eligible to use Дуо-Септол?

Eligibility criteria and restrictions for using this medicine are detailed in official regulatory documents from government agencies worldwide. These sources include the FDA Prescribing Information, the EMA Summary of Product Characteristics (SmPC), and national drug monographs.


Q: Does the evidence for Дуо-Септол come mainly from clinical trials?

The foundational knowledge supporting the use and efficacy of Дуо-Септол is derived from clinical trials. These trial results are often summarized in comprehensive analyses, such as systematic reviews and meta-analyses, which are used to establish its indications and dosage guidelines.


Q: Can Дуо-Септол be used on an empty stomach?

According to official patient information, Дуо-Септол can generally be taken either with or without food. Taking the medicine with food or drink is often noted as a way to help reduce potential gastrointestinal upset, such as nausea or diarrhea.


Q: What is the regulatory status of Дуо-Септол in different countries?

The active ingredient combination, known internationally as Co-trimoxazole, holds significant regulatory recognition globally. It is included on the World Health Organization (WHO) Model List of Essential Medicines and is licensed and regulated by major governmental health authorities.


Q: What official resources describe how to dispose of unused Дуо-Септол?

Government drug agencies advise patients on safe drug disposal practices. These practices typically instruct the public to return unused or expired medication to a local medicine take-back program or an authorized collection site, rather than discarding it in the regular trash or flushing it down a drain.


Q: What is the expected experience of a patient starting Дуо-Септол?

The initial phase of use may involve commonly reported, often mild side effects. Official documents note these often include gastrointestinal disturbances like nausea or vomiting, a general loss of appetite, or the development of a rash.


Q: Is it normal to feel a minor side effect like a dry mouth when using Дуо-Септол?

Dry mouth is not listed as one of the most common or frequently reported side effects in the primary regulatory labels for this medicine. Information indicates that dry mouth is not listed as a common effect, and patients experiencing it are advised to consult their healthcare professional.


Q: Can Дуо-Септол interact with common pain relievers?

The official interaction warnings for Дуо-Септол list specific, clinically significant interactions with certain prescription medications. Since official labeling does not categorize all non-prescription pain relievers broadly, patients are advised via official channels to report all over-the-counter medicines they use.


Q: How quickly does Дуо-Септол typically start to work?

Pharmacokinetic data shows that peak concentrations of the active ingredients in the blood are reached relatively quickly, typically within one to four hours after taking an oral dose. However, the resulting clinical anti-infective effect takes longer to fully manifest.


Q: Is Дуо-Септол known to cause drowsiness?

Regulatory documents often do not list drowsiness as a prominent side effect. However, patients should use caution if they experience any dizziness or other effects that could impair their concentration or reaction time.


Q: What should be done if someone accidentally uses too much Дуо-Септол?

Official patient information states that immediate emergency medical attention should be sought in the event of an overdose. Guidance typically recommends contacting a Poison Control Center, and notes that supportive measures are generally administered in a clinical setting.


Q: Are there any known interactions between Дуо-Септол and herbal supplements?

Regulatory agencies advise patients to report all herbal products and supplements they are using, as information on all potential interactions may not be fully established. This helps manage the risk of unlisted or unknown interactions.


Q: Are there any restrictions on driving or operating machinery while using Дуо-Септол?

Official guidance on the ability to drive or operate machines states that studies may not have been conducted on this specific topic. Patients should exercise caution if they experience any side effects, such as dizziness, that could impair their ability to safely perform these tasks.


Q: Can Дуо-Септол be used alongside vitamins?

Since the drug can affect the body's folate metabolism, official guidance sometimes addresses the co-administration of vitamins. Folic acid supplementation may be administered concurrently to patients who are at risk of folate depletion, and this does not typically interfere with the drug's primary antibacterial action.


Q: Is it possible for Дуо-Септол to affect laboratory test results?

Regulatory prescribing information notes that the drug may interfere with certain common laboratory tests. Specifically, it has the potential to interfere with the Jaffe alkaline picrate assay, which is used to measure creatinine, potentially causing a falsely high reading.


Q: Are there any specific safety rules regarding the use of Дуо-Септол with alcohol?

Co-administration of this medicine with alcohol should be approached cautiously. Some regulatory sources indicate that in certain patients, using the drug alongside alcohol may lead to an acute intolerance reaction, which can involve symptoms like flushing, nausea, or vomiting.


Q: Why is it important to complete the full course of Дуо-Септол?

Completing the full course of treatment as prescribed is advised to support the elimination of the infection and to minimize the risk of bacterial resistance developing. This practice is detailed in patient information from official sources.


Q: Does Дуо-Септол contain lactose or gluten?

The specific content of inactive ingredients (excipients) can vary by formulation and manufacturer. While some tablet formulations may not list common allergens like lactose or gluten in their official excipient lists, patients concerned about allergies should reference the product-specific labeling.


Q: What factors might make Дуо-Септол less effective?

Official guidance indicates that its effectiveness can be reduced by factors related to proper administration. Factors that may reduce effectiveness include deviation from the prescribed dosing schedule, such as missed doses, or the failure to complete the full treatment duration as specified in official guidelines.


Q: Can I use Дуо-Септол if I have an existing heart condition?

While a general heart condition is not a universal contraindication, official documentation notes several important drug interactions related to cardiac function. For example, it is specifically contraindicated with the antiarrhythmic drug Dofetilide due to the risk of serious heart rhythm issues (Torsades de pointes).


Q: Does Дуо-Септол interact with birth control pills?

Clinical reviews suggest that short courses of the medicine are generally not associated with significantly compromising the effectiveness of birth control, as the drug may only minimally influence the concentration of the estrogen component in some oral contraceptives. Patients should seek clarification on their specific regimen.


Q: What should a patient do if they experience a severe side effect from Дуо-Септол?

Official safety information advises that patients stop taking the drug immediately and seek emergency medical attention upon the first signs of a severe adverse reaction. This action is critical for symptoms such as a serious rash, fever, or sudden changes in blood parameters.


Q: Are there any reported cases of resistance developing to Дуо-Септол?

The use of the drug in clinical practice is frequently related to treating infections where antimicrobial resistance is a concern. Continuous susceptibility testing and monitoring are essential processes utilized by healthcare systems to track patterns of bacterial resistance.


Q: Can I take other cold and flu medicines while using Дуо-Септол?

Official prescribing information advises exercising caution with the use of all other medicines. Patients should seek clarification regarding any non-prescription cold and flu treatments to check for potential drug interactions.

Advertisements

How should Дуо-Септол be stored and disposed of?

How to Store and Dispose of Дуо-Септол (Co-trimoxazole)

The official storage and disposal guidelines for this medication are defined by regulatory agencies to maintain its potency and ensure safety.

Official Storage Requirements

Requirement Description
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Keep the container tightly closed and protect the product from light and moisture.
Prohibition Do not freeze the oral suspension or intravenous solution.
Child Safety Keep out of the reach and sight of children.

Disposal Instructions

Expired or unused product must be disposed of safely. Do not flush the medicine down the toilet or pour it into a drain. The product should be returned to a local medicine take-back program or an authorized collection site to ensure proper pharmaceutical waste handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Дуо-Септол found in:

A-Z Index: